Long-term treatment with low-dose metoprolol CR/XL is associated with increased plaque echogenicity: The Beta-blocker Cholesterol-lowering Asymptomatic Plaque Study (BCAPS).

Gerd Östling, Isabel Goncalves, John Wikstrand, Göran Berglund, Jan Nilsson, Bo Hedblad

Research output: Contribution to journal › Article › peer-review

200 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Long-term treatment with low-dose metoprolol CR/XL is associated with increased plaque echogenicity: The Beta-blocker Cholesterol-lowering Asymptomatic Plaque Study (BCAPS).'. Together they form a unique fingerprint.

Medicine & Life Sciences